封面
市场调查报告书
商品编码
1982762

全球低内毒素明胶市场规模、份额、趋势和成长分析报告(2026-2034年)

Global Low Endotoxin Gelatin Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 174 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计低内毒素明胶市场将从 2025 年的 2.6705 亿美元成长到 2034 年的 4.6241 亿美元,2026 年至 2034 年的复合年增长率为 6.29%。

由于低内毒素明胶在製药和生物技术领域的重要性,全球低内毒素明胶市场持续成长。低内毒素明胶经过特殊加工去除细菌内毒素,适用于药物传递系统、疫苗和生物医学研究等对物质含量要求较高的医疗应用。医疗领域对高纯度材料日益增长的需求,显着推动了对这种特殊明胶的需求。

多种因素正在推动低内毒素明胶市场的扩张。製药和生物技术产业的快速发展增加了对医疗产品所用高品质原料的需求。此外,药物研发和再生医学研究活动的活性化也扩大了低内毒素明胶在实验室和临床环境中的应用。

随着生物医学研究的进步,低内毒素明胶市场预计将持续成长。製药生产的创新以及对安全有效医疗产品日益增长的需求,预计将进一步推动高纯度明胶材料的应用。此外,生物技术研究的拓展预计也将为市场的长期发展提供支持。

目录

第一章:引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章:全球低内毒素明胶市场:依产品类型划分

  • 市场分析、洞察与预测
  • A型
  • B型

第五章:全球低内毒素明胶市场:依来源划分

  • 市场分析、洞察与预测
  • 源自猪
  • 源自牛
  • 其他的

第六章:全球低内毒素明胶市场:依应用领域划分

  • 市场分析、洞察与预测
  • 製药
  • 医疗设备
  • 生物技术
  • 研究与开发
  • 其他的

第七章:全球低内毒素明胶市场:依最终用户划分

  • 市场分析、洞察与预测
  • 医院
  • 研究机构
  • 製药公司
  • 其他的

第八章 全球低内毒素明胶市场:依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第九章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴(根据现有资讯)
  • 市场占有率和市场定位分析(基于现有资讯)
  • 供应商情况(基于现有资讯)
  • 策略规划

第十章:公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Gelita AG
    • Nitta Gelatin Inc
    • Rousselot BV
    • PB Gelatins/PB Leiner
    • Weishardt Group
    • Sterling Gelatin
    • Great Lakes Gelatin Company
    • Tessenderlo Group
    • Lapi Gelatine SPA
    • Qinghai Gelatin Co. Ltd
    • India Gelatine & Chemicals Ltd
    • Geltech Co. Ltd
    • Narmada Gelatines Ltd
    • Trobas Gelatine BV
    • Junca Gelatines SL
简介目录
Product Code: VMR11212364

The Low Endotoxin Gelatin Market size is expected to reach USD 462.41 Million in 2034 from USD 267.05 Million (2025) growing at a CAGR of 6.29% during 2026-2034.

The global low endotoxin gelatin market has grown steadily due to its importance in pharmaceutical and biotechnology applications. Low endotoxin gelatin is specially processed to remove bacterial endotoxins, making it suitable for sensitive medical uses such as drug delivery systems, vaccines, and biomedical research. The increasing focus on high-purity materials in healthcare has significantly boosted demand for this specialized gelatin.

Several factors are driving the expansion of the low endotoxin gelatin market. The rapid growth of the pharmaceutical and biotechnology industries has increased the need for high-quality raw materials used in medical products. Additionally, rising research activities in drug development and regenerative medicine have expanded the use of low endotoxin gelatin in laboratory and clinical settings.

In the future, the low endotoxin gelatin market is expected to continue growing as biomedical research advances. Innovations in pharmaceutical manufacturing and increasing demand for safe and effective medical products may drive further adoption of high-purity gelatin materials. Furthermore, expanding biotechnology research initiatives will likely support long-term market development.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

  • Type A
  • Type B

By Source

  • Porcine
  • Bovine
  • Fish
  • Others

By Application

  • Pharmaceuticals
  • Medical Devices
  • Biotechnology
  • Research and Development
  • Others

By End-User

  • Hospitals
  • Research Institutes
  • Pharmaceutical Companies
  • Others

COMPANIES PROFILED

  • Gelita AG, Nitta Gelatin Inc, Rousselot BV, PB GelatinsPB Leiner, Weishardt Group, Sterling Gelatin, Great Lakes Gelatin Company, Tessenderlo Group, Lapi Gelatine Spa, Qinghai Gelatin Co Ltd, India Gelatine Chemicals Ltd, Geltech Co Ltd, Narmada Gelatines Ltd, Trobas Gelatine BV, Junca Gelatines SL
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL LOW ENDOTOXIN GELATIN MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product Type
  • 4.2. Type A Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Type B Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL LOW ENDOTOXIN GELATIN MARKET: BY SOURCE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Source
  • 5.2. Porcine Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Bovine Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Fish Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL LOW ENDOTOXIN GELATIN MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Pharmaceuticals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Medical Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Biotechnology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Research and Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL LOW ENDOTOXIN GELATIN MARKET: BY END-USER 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End-user
  • 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL LOW ENDOTOXIN GELATIN MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Product Type
    • 8.2.2 By Source
    • 8.2.3 By Application
    • 8.2.4 By End-user
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Product Type
    • 8.3.2 By Source
    • 8.3.3 By Application
    • 8.3.4 By End-user
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Product Type
    • 8.4.2 By Source
    • 8.4.3 By Application
    • 8.4.4 By End-user
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Product Type
    • 8.5.2 By Source
    • 8.5.3 By Application
    • 8.5.4 By End-user
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Product Type
    • 8.6.2 By Source
    • 8.6.3 By Application
    • 8.6.4 By End-user
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL LOW ENDOTOXIN GELATIN INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Gelita AG
    • 10.2.2 Nitta Gelatin Inc
    • 10.2.3 Rousselot BV
    • 10.2.4 PB Gelatins/PB Leiner
    • 10.2.5 Weishardt Group
    • 10.2.6 Sterling Gelatin
    • 10.2.7 Great Lakes Gelatin Company
    • 10.2.8 Tessenderlo Group
    • 10.2.9 Lapi Gelatine S.P.A
    • 10.2.10 Qinghai Gelatin Co. Ltd
    • 10.2.11 India Gelatine & Chemicals Ltd
    • 10.2.12 Geltech Co. Ltd
    • 10.2.13 Narmada Gelatines Ltd
    • 10.2.14 Trobas Gelatine BV
    • 10.2.15 Junca Gelatines SL